Geode Capital Management’s Microbot Medical MBOT Stock Holding History

Geode Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Sell	760,831 -1,164	-0.2%	-$2.6K	﹤0.01%	3158
2025 Q4	$1.52M	Buy	761,995 +268,609	+54%	+$636K	﹤0.01%	3247
2025 Q3	$1.51M	Buy	493,386 +98,347	+25%	+$307K	﹤0.01%	3278
2025 Q2	$996K	Buy	395,039 +78,121	+25%	+$187K	﹤0.01%	3324
2025 Q1	$479K	Buy	316,918 +174,259	+122%	+$308K	﹤0.01%	3560
2024 Q4	$160K	Buy	142,659 +10,442	+8%	+$10.2K	﹤0.01%	3964
2024 Q3	$118K	Buy	132,217 +12,280	+10%	+$12K	﹤0.01%	4056
2024 Q2	$122K	Buy	119,937 +27,533	+30%	+$28.3K	﹤0.01%	4078
2024 Q1	$114K	Hold	92,404	–	–	﹤0.01%	4125
2023 Q4	$152K	Hold	92,404	–	–	﹤0.01%	4037
2023 Q3	$128K	Buy	92,404 +39,482	+75%	+$85.6K	﹤0.01%	4160
2023 Q2	$144K	Hold	52,922	–	–	﹤0.01%	4192
2023 Q1	$110K	Hold	52,922	–	–	﹤0.01%	4306
2022 Q4	$159K	Sell	52,922 -131	-0.2%	-$544	﹤0.01%	4212
2022 Q3	$253K	Buy	53,053 +1,235	+2%	+$6.35K	﹤0.01%	4070
2022 Q2	$265K	Buy	51,818 +1,314	+3%	+$7.31K	﹤0.01%	4098
2022 Q1	$316K	Hold	50,504	–	–	﹤0.01%	4159
2021 Q4	$378K	Hold	50,504	–	–	﹤0.01%	4184
2021 Q3	$355K	Hold	50,504	–	–	﹤0.01%	4183
2021 Q2	$401K	Hold	50,504	–	–	﹤0.01%	4039
2021 Q1	$429K	Hold	50,504	–	–	﹤0.01%	3865
2020 Q4	$347K	Hold	50,504	–	–	﹤0.01%	3715
2020 Q3	$385K	Hold	50,504	–	–	﹤0.01%	3508
2020 Q2	$348K	Hold	50,504	–	–	﹤0.01%	3489
2020 Q1	$280K	Buy	50,504 +8,539	+20%	+$74.8K	﹤0.01%	3449
2019 Q4	$426K	Buy	41,965 +231	+0.6%	+$1.35K	﹤0.01%	3558
2019 Q3	$221K	Hold	41,734	–	–	﹤0.01%	3731
2019 Q2	$214K	Hold	41,734	–	–	﹤0.01%	3772
2019 Q1	$323K	Buy	41,734 +19,583	+88%	+$152K	﹤0.01%	3590
2018 Q4	$38K	Buy	+22,151	New	+$83.8K	﹤0.01%	4028
2018 Q3	–	Sell	-2,413	Closed	-$26K	–	4136
2018 Q2	$26K	Hold	2,413	–	–	﹤0.01%	4025
2018 Q1	$24K	Sell	2,413 -136	-5%	-$1.84K	﹤0.01%	4010
2017 Q4	$38K	Sell	2,549 -783	-23%	-$13.3K	﹤0.01%	3952
2017 Q3	$58K	Hold	3,332	–	–	﹤0.01%	3912
2017 Q2	$70K	Sell	3,332 -219	-6%	-$12.1K	﹤0.01%	3894
2017 Q1	$312K	Buy	3,551 +2,220	+167%	+$195K	﹤0.01%	3493
2016 Q4	$121K	Buy	1,331 +1,031	+344%	+$130K	﹤0.01%	3747
2016 Q3	$55K	Hold	300	–	–	﹤0.01%	3903
2016 Q2	$16K	Hold	300	–	–	﹤0.01%	4038
2016 Q1	$126	Hold	300	–	–	﹤0.01%	3769
2015 Q4	$202K	Buy	300 +27	+10%	+$19.8K	﹤0.01%	3685
2015 Q3	$185K	Hold	273	–	–	﹤0.01%	3708
2015 Q2	$238K	Buy	273 +93	+52%	+$109K	﹤0.01%	3519
2015 Q1	$297K	Hold	180	–	–	﹤0.01%	3426
2014 Q4	$273K	Hold	180	–	–	﹤0.01%	3452
2014 Q3	$367K	Buy	180 +51	+40%	+$135K	﹤0.01%	3301
2014 Q2	$424K	Hold	129	–	–	﹤0.01%	3234
2014 Q1	$280K	Buy	129 +28	+28%	+$67K	﹤0.01%	3384
2013 Q4	$201K	Sell	101 -1	-1%	-$2.12K	﹤0.01%	3432
2013 Q3	$277K	Buy	102 +34	+50%	+$92.2K	﹤0.01%	3184
2013 Q2	$182K	Buy	+68	New	+$192K	﹤0.01%	3262

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management's MBOT Position: Q1 2026 in Review

Geode Capital Management reduced its Microbot Medical (MBOT) stake by 0.15% in Q1 2026, selling an estimated $2.6K and leaving 760,831 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Geode Capital Management first reported a position in MBOT in Q2 2013 and has held it in 51 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Geode Capital Management held 760,831 shares of Microbot Medical worth $1.83M as of Q1 2026.
Geode Capital Management sold 1,164 Microbot Medical shares in Q1 2026, an estimated $2.6K.
Microbot Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3158 holding.
Geode Capital Management first reported a position in Microbot Medical in Q2 2013 and has held it in 51 quarters since.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.